BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Inflammatory disorder
,
Breast
,
Avian flu virus
,
Fluoxetine
,
rs3825942
,
TGFB1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
STGD1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Tongue
Adrenal gland
Fetal liver
Fetal thyroid
Atrioventricular node
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Formulation and efficacy of ECO/pRHO-ABCA4-SV40 nanoparticles for nonviral gene therapy of Stargardt…
Lutein and zeaxanthin reduce A2E and iso-A2E levels and improve visual performance in Abca4-/-/Bco2-…
Cell-Type-Specific Complement Profiling in the ABCA4-/- Mouse Model of Stargardt Disease.
Non-viral Gene Therapy for Stargardt Disease with ECO/pRHO-ABCA4 Self-Assembled Nanoparticles.
An AAV Dual Vector Strategy Ameliorates the Stargardt Phenotype in Adult Abca4-/- Mice.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study to Evaluate the Safety and Efficacy of Tinlarebant in the Treatment of Stargardt Disease in Ad…
Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)
Study of STG-001 in Subjects With Stargardt Disease
This is a Dose-finding Study Followed by 2-year Extension Study to Evaluate Safety and Tolerability …
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Relat…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ